Cytokinetics, Incorporated · NASDAQ:CYTK

Malik Fady Ibraham sold 3,500 Cytokinetics, Incorporated shares (Form 4)

Traded Oct 6, 2026 · Filed Oct 6, 2026

On Oct 6, 2026, Malik Fady Ibraham (EVP Research & Development) sold 3,500 Cytokinetics, Incorporated shares at US$61.38 for US$215K under a trading plan, leaving 153,902 shares. Filed Oct 6, 2026 (Form 4).

Sold
3,500 shares
Price
US$61.38
Value
US$215K
Holding after
153,902 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP Research & Development

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 6, 2026Common StockOption exercise3,500US$7.80157,402Direct
Oct 6, 2026Common StockSale3,500US$61.38153,902Direct

Source

View original at SEC

Related